• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 27, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Improving detection of a ‘date rape’ drug

Bioengineer by Bioengineer
August 9, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Because gamma hydroxybutyric acid (GHB), commonly known as a "date rape drug" is rapidly absorbed and metabolized by the body, it's difficult for law enforcement to tell if someone has been given GHB. Now, scientists report in ACS' journal Analytical Chemistry that they have identified a potential biomarker that might lead to tests to detect the compound that could be performed much later than current ones.

When ingested, GHB can make a person groggy or sleepy and can induce amnesia. As a prescription drug, it is used to treat narcolepsy, a sleep disorder, as well as relieve pain, fatigue and other symptoms of fibromyalgia. But it also has been used as a recreational club drug and has been linked to thousands of sexual assault cases. Current techniques can only detect GHB in the first few hours after ingestion. In addition they require considerable modifications to the samples that can skew the results or even destroy the evidence. To address these challenges, Míriam Pérez-Trujillo and colleagues wanted to see if they could identify a biomarker of the drug that would stay in urine or blood a lot longer than GHB itself does. They also wanted to find a method that would not require extensive sample manipulation.

The researchers studied samples from a clinical trial in which volunteers received small doses of GHB. Blood and urine samples were taken from trial participants at regular intervals over 30 hours following ingestion. The scientists analyzed the samples using nuclear magnetic resonance spectroscopy and found that they could detect GHB in urine samples taken up to 2 hours after ingestion. They also could distinguish GHB from other similar drugs. Importantly, the researchers found that glycolate, a metabolite of GHB, might be a good biomarker for the drug. They could measure its levels in urine for up to 20 hours after the drug was taken. This finding could form the basis for tests that could be performed much later than current ones. And, because technique didn't damage or destroy the samples, further analyses with other methods are possible.

###

The authors acknowledge the Drug Control Centre at King's College London for kindly providing samples, and funding and support from the MINECO, a Jose Castillejos mobility fellowship from the Spanish government, an Erasmus+ trainee fellowship from the European Union and a King's-China scholarship.

The abstract that accompanies this study is available here.

The American Chemical Society, the world's largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.

To automatically receive news releases from the American Chemical Society, contact [email protected].

Follow us on Twitter | Facebook

Media Contact

Katie Cottingham
[email protected]
301-775-8455
@ACSpressroom

http://www.acs.org

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

CircCOG5 Regulates Ferroptosis in Ovarian Cancer

August 27, 2025
blank

Heat Stress Impact on Aged Hens’ Health and Performance

August 27, 2025

Achieving Weight Goals Within Four Years: A Scientific Breakthrough

August 27, 2025

Exploring Fungal Diversity via Metabarcoding Techniques

August 27, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    148 shares
    Share 59 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New 18F-labeled Compound Targets COX-2 Imaging

New Study Highlights Positive Impact of Diet and Exercise on Alcohol-Induced Liver Damage

CytoSorb® Enhanced Hemadsorption in Cardiac Surgery Outcomes

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.